🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of Tylenol, claiming the corporations concealed safety concerns that the medication presented to children's neurological development.

This legal action follows four weeks after President Donald Trump publicized an unproven link between taking Tylenol - also known as acetaminophen - throughout gestation and autism spectrum disorder in children.

Paxton is suing Johnson & Johnson, which previously sold the drug, the sole analgesic recommended for pregnant women, and Kenvue, which presently makes it.

In a statement, he claimed they "misled consumers by gaining financially from suffering and pushing pills ignoring the dangers."

Kenvue states there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These companies lied for decades, intentionally threatening numerous people to boost earnings," Paxton, from the Republican party, declared.

The company stated officially that it was "very worried by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the health of women and children in America."

On its official site, Kenvue also stated it had "continuously evaluated the relevant science and there is lacking reliable evidence that demonstrates a proven link between using paracetamol and autism."

Organizations representing physicians and healthcare providers share this view.

The leading OB-GYN organization has stated acetaminophen - the main ingredient in acetaminophen - is a restricted selection for pregnant women to address discomfort and elevated temperature, which can present significant medical dangers if not addressed.

"In over twenty years of studies on the consumption of paracetamol in gestation, zero credible investigations has conclusively proven that the use of acetaminophen in any period of pregnancy causes neurological conditions in young ones," the group commented.

This legal action references recent announcements from the former administration in claiming the medication is allegedly unsafe.

Recently, Trump raised alarms from medical authorities when he instructed expectant mothers to "struggle intensely" not to consume acetaminophen when ill.

The US Food and Drug Administration then released a statement that medical professionals should think about restricting the use of Tylenol, while also mentioning that "a proven link" between the drug and autism spectrum disorder in children has remains unverified.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had vowed in spring to initiate "a massive testing and research effort" that would determine the source of autism in a short period.

But experts advised that identifying a unique factor of autism - thought by researchers to be the result of a complicated interplay of inherited and surrounding conditions - would be difficult.

Autism is a form of permanent neurological difference and disability that influences how persons perceive and engage with the environment, and is identified using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is running for US Senate - claims Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the evidence" around acetaminophen and autism.

The lawsuit attempts to require the corporations "destroy any commercial messaging" that claims Tylenol is reliable for expectant mothers.

The court case mirrors the concerns of a collection of guardians of minors with autism and attention deficit hyperactivity disorder who filed suit against the producers of acetaminophen in 2022.

The court threw out the lawsuit, stating research from the parents' expert witnesses was inconclusive.